BP707T · Semester 7 · B.Pharm
Unit V — Clinical Trials, Ethics and Post-Marketing Surveillance
Regulatory Affairs
This study page introduces Clinical Trials, Ethics and Post-Marketing Surveillance in Regulatory Affairs (BP707T), B.Pharm Semester 7. Read the selected definitions and short notes below, then download the full unit PDF.
Topics in this unit
- Global Registration of Indian Drug Products and Post-Approval Changes
- Clinical Research Phases and Trial Documents
- IRB/IEC, Informed Consent and GCP Obligations
- Pharmacovigilance During Clinical Trials and Post-Marketing
Definitions and short notes
Selected extracts from this unit’s notes. Download the full PDF below for the remaining topics and examples.
Global registration
The process of getting a drug product approved for sale in foreign (overseas) countries — one country at a time, following each country's own rules. "Global" here means "in world markets outside India."
Unit PDF · page 2
Overseas market
Any country's medicine market outside India (for example, the United States, Europe, or ASEAN countries, from an Indian company's point of view).
Unit PDF · page 2
Download notes
Save the PDF for offline reading. On some browsers, the file opens first; use the PDF viewer’s download button to save it.
For education and exam preparation only, not medical advice or current regulatory guidance.